Try Alerts Free   |   Login
Consumer Staples › Agriculture Chemicals

Arcadia Biosciences (RKDA) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 24 quarters since 2015. Compare with RKDA stock chart to see long term trends.

RKDA stock compared to

RKDA Income Statement

Revenue, Net:7130000
Revenue Per Share:0.72
Selling, General & Admin Expense:4778000
Research & Development Expense:1961000
Total Operating Expenses:-339000
Operating Income:7469000
Income Taxes:-140000
Net Income:8508000
Earnings Per Share, Basic:0.88
Shares Outstanding, Basic Avg:9959018

RKDA Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:1348000
Net Cash from Operations:-6751000
Net Cash from Financing Activities:7736000
Property, Plant & Equipment Purchases:297000
Net Cash from Investing Activities:2856000
Net Change in Cash & Equivalents:3841000

RKDA Balance Sheet

Cash and Cash Equivalents:16043000
Short-Term Investments:11625000
Accounts Receivable, Net:1406000
Total Current Assets:31696000
Property, Plant & Equipment, Net:3539000
Total Assets:47348000
Total Short-Term Liabilities:6314000
Long Term Debt, Non-Current Portion:2105000
Total Liabilities:18796000

Major Holders (from 13F filings)

Investment Type
Value (x$1000)
increase or decrease
Sabby Management, LLC
275,123 sh
215,580 sh
Vanguard Group Inc
256,393 sh
Ardsley Advisory Partners Lp
25,000 sh
25,000 sh
Blackrock Inc.
21,462 sh
-1,001 sh
Northern Trust Corp
21,282 sh
2,997 sh
Morgan Stanley
1,070 sh
-11,099 sh
Virtu Financial LLC
0 sh
-29,944 sh
Bank Of America Corp /De/
0 sh
-43 sh
Proequities, Inc.
0 sh

Data imported from Arcadia Biosciences Inc SEC filings. Check original filings before making any investment decision.